Olema Oncology Jobs in United States

Join to apply for the Director, Clinical Monitoring Oversight role at Olema Oncology · Olema Oncology is dedicated to developing better medicines for breast cancer and beyond. Our lead program, palazestrant (OP-1250), is a complete estrogen receptor antagonist (CERAN) currently i ...

Olema Oncology is dedicated to developing better medicines for breast cancer and beyond. Our lead program, palazestrant (OP-1250), is a complete estrogen receptor antagonist (CERAN) currently in development for metastatic breast cancer with blockbuster potential as a monotherapy ...

· Olema Oncology is dedicated to developing better medicines for breast cancer and beyond. Our lead program, palazestrant (OP-1250), is a complete estrogen receptor antagonist (CERAN) currently in development for metastatic breast cancer with blockbuster potential as a monothera ...

Olema Oncology is dedicated to developing better medicines for breast cancer and beyond. This Senior Director of Clinical Business Operations will support the Clinical Department's initiatives to contribute to the success of our clinical trials. · ...

Olema Oncology accelerates scientific breakthroughs through teamwork. · Participate in cross-functional study teams ensuring GCP/GVP compliance · About Us: · We develop better medicines for breast cancer and beyond. · ...

Olema Oncology is developing medicines for breast cancer. · We are a pragmatic team, driven to imagine and develop meaningful therapies for improving lives. · This role will provide strategic direction and operational oversight of all global monitoring activities across Olema's c ...

Join to apply for the Director, Analytical Development role at Olema Oncology · Olema Oncology is dedicated to developing better medicines for breast cancer and beyond. Our lead program, palazestrant (OP-1250), is a complete estrogen receptor antagonist (CERAN) currently in devel ...

Olema Oncology is dedicated to developing better medicines for breast cancer and beyond. Our lead program, palazestrant (OP-1250), is a complete estrogen receptor antagonist (CERAN) currently in development for metastatic breast cancer with blockbuster potential as a monotherapy ...

· Olema Oncology is dedicated to developing better medicines for breast cancer and beyond. Our lead program, palazestrant (OP-1250), is a complete estrogen receptor antagonist (CERAN) currently in development for metastatic breast cancer with blockbuster potential as a monothera ...

Olema Oncology is dedicated to developing better medicines for breast cancer and beyond. Our lead program, palazestrant (OP-1250), is a complete estrogen receptor antagonist (CERAN) currently in development for metastatic breast cancer with blockbuster potential as a monotherapy ...

· Olema Oncology is dedicated to developing better medicines for breast cancer and beyond. Our lead program, palazestrant (OP-1250), is a complete estrogen receptor antagonist (CERAN) currently in development for metastatic breast cancer with blockbuster potential as a monothera ...

· Olema Oncology is dedicated to developing better medicines for breast cancer and beyond. Our lead program, palazestrant (OP-1250), is a complete estrogen receptor antagonist (CERAN) currently in development for metastatic breast cancer with blockbuster potential as a monothera ...

A leading biotechnology company is seeking a Director of Analytical Development in San Francisco. In this role, you will oversee analytical method innovations and ensure compliance with regulatory standards for drug development. The ideal candidate has substantial experience in a ...

Senior Manager GCP Quality Assurance · Olema Oncology is dedicated to developing better medicines for breast cancer and beyond. · Our lead program, palazestrant (OP-1250), is a complete estrogen receptor antagonist (CERAN) currently in development for metastatic breast cancer wit ...

Job Overview · We are seeking a Senior Manager, Global Regulatory Affairs Strategy who will provide regulatory strategy support in partnership with cross-functional teams and subject matter experts and manage regulatory aspects through all phases of development. · About You · You ...

· Olema Oncology is dedicated to developing better medicines for breast cancer and beyond. Our lead program, palazestrant (OP-1250), is a complete estrogen receptor antagonist (CERAN) currently in development for metastatic breast cancer with blockbuster potential as a monothera ...

· Olema Oncology is dedicated to developing better medicines for breast cancer and beyond. Our lead program, palazestrant (OP-1250), is a complete estrogen receptor antagonist (CERAN) currently in development for metastatic breast cancer with blockbuster potential as a monothera ...

Olema Oncology is dedicated to developing better medicines for breast cancer and beyond. Our lead program, palazestrant (OP-1250), is a complete estrogen receptor antagonist (CERAN) currently in development for metastatic breast cancer with blockbuster potential as a monotherapy ...

Director of Facilities · Olema Oncology aims to develop innovative medicines for breast cancer treatment. · We are looking for a Director of Facilities who will lead our facilities operations and laboratory environments across multiple sites. · ...

+Job summary · Olema Oncology is dedicated to developing better medicines for breast cancer and beyond. · +Lead the development of the New Drug Application (NDA) · Develop innovative global regulatory strategies for the Olema portfolio of products in clinical development and life ...